Daynna Wolff to Reproducibility of Results
This is a "connection" page, showing publications Daynna Wolff has written about Reproducibility of Results.
Connection Strength
0.197
-
A multicenter, cross-platform clinical validation study of cancer cytogenomic arrays. Cancer Genet. 2015 Nov; 208(11):525-36.
Score: 0.087
-
Developing a sustainable process to provide quality control materials for genetic testing. Genet Med. 2005 Oct; 7(8):534-49.
Score: 0.044
-
Clinical investigational studies for validation of a next-generation sequencing in vitro diagnostic device for cystic fibrosis testing. Expert Rev Mol Diagn. 2014 Jun; 14(5):605-22.
Score: 0.020
-
American College of Medical Genetics and Genomics technical standards and guidelines: microarray analysis for chromosome abnormalities in neoplastic disorders. Genet Med. 2013 Jun; 15(6):484-94.
Score: 0.018
-
Validation of fluorescence in situ hybridization using an analyte-specific reagent for detection of abnormalities involving the mixed lineage leukemia gene. Arch Pathol Lab Med. 2012 Jan; 136(1):47-52.
Score: 0.017
-
HER-2 fluorescence in situ hybridization: results from the survey program of the College of American Pathologists. Arch Pathol Lab Med. 2006 Mar; 130(3):325-31.
Score: 0.011